emergent biosolutions inc (EBS:New York)
Transactions by EMERGENT BIOSOLUTIONS INC (EBS) in the last 6 months
Emergent BioSolutions, Inc. (NYSE:EBS) agreed to spin-off Biosciences Business on August 6, 2015. The new Biosciences company will be named later on. Emergent will maintain its headquarters in Gaithersburg, Maryland and other facilities as well. Emergent expects to provide the new company with a fixed cash contribution of $50 million to $70 million. Emergent and the new company will have separate management teams and boards of directors. Daniel J. Abdun-Nabi will remain ...
ProMetic Life Sciences Inc. (TSX:PLI) agreed to acquire Plasma Collection Facility from Emergent BioSolutions, Inc. (NYSE:EBS) on May 28, 2015. All existing centre employees will then transition to be employed by ProMetic. The transaction is subject to customary closing conditions.
|Albany Molecular Research Inc||$19.60 USD||-0.34|
|Bavarian Nordic A/S||kr288.00 DKK||-4.50|
|Depomed Inc||$26.08 USD||-0.85|
|Impax Laboratories Inc||$40.63 USD||-0.33|
|Nektar Therapeutics||$10.75 USD||-0.30|
|View Industry Companies|